Search Results
You are looking at 1 - 7 of 7 items for
- Author: Jie Liu x
- Refine by access: All content x
Search for other papers by Jinke Wang in
Google Scholar
PubMed
Search for other papers by Jie Lu in
Google Scholar
PubMed
Search for other papers by Guangming Gu in
Google Scholar
PubMed
Search for other papers by Yingxun Liu in
Google Scholar
PubMed
The DNA-binding specificity of transcription factors (TFs) has broad impacts on cell physiology, cell development and in evolution. However, the DNA-binding specificity of most known TFs still remains unknown. The specificity of a TF protein is determined by its relative affinity to all possible binding sites. In recent years, the development of several in vitro techniques permits high-throughput determination of relative binding affinity of a TF to all possible k bp-long DNA sequences, thus greatly promoting the characterization of DNA-binding specificity of many known TFs. All DNA sequences that can be bound by a TF with various binding affinities form their DNA-binding profile (DBP). The DBP is important to generate an accurate DNA-binding model, identify all DNA-binding sites and target genes of TFs in the whole genome, and build transcription regulatory network. This study reviewed these techniques, especially two master techniques: double-stranded DNA microarray and systematic evolution of ligands by exponential enrichment in combination with parallel DNA sequencing techniques (SELEX-seq).
Search for other papers by Shou-Si Lu in
Google Scholar
PubMed
Search for other papers by Yun-Li Yu in
Google Scholar
PubMed
Search for other papers by Hao-Jie Zhu in
Google Scholar
PubMed
Search for other papers by Xiao-Dong Liu in
Google Scholar
PubMed
Search for other papers by Li Liu in
Google Scholar
PubMed
Search for other papers by Yao-Wu Liu in
Google Scholar
PubMed
Search for other papers by Ping Wang in
Google Scholar
PubMed
Search for other papers by Lin Xie in
Google Scholar
PubMed
Search for other papers by Guang-Ji Wang in
Google Scholar
PubMed
Berberine (BBR), a hypoglycemic agent, has shown beneficial metabolic effects for anti-diabetes, but its precise mechanism was unclear. Glucagon-like peptide-1 (GLP-1) is considered to be an important incretin that can decrease hyperglycemia in the gastrointestinal tract after meals. The aim of this study was to investigate whether BBR exerts its anti-diabetic effects via modulating GCG secretion. Diabetes-like rats induced by streptozotocin received BBR (120 mg/kg per day, i.g) for 5 weeks. Two hours following the last dose, the rats were anaesthetized and received 2.5 g/kg glucose by gavage. At 15-minute and 30-minute after glucose load, blood samples, pancreas, and intestines were obtained to measure insulin and GCG using ELISA kit. The number of L cells in the ileum and β-cells in the pancreas were identified using immunohistology. The expression of proglucagon mRNA in the ileum was measured by RT-PCR. The results indicated that BBR treatment significantly increased GCG levels in plasma and intestine (P<0.05) accompanied with the increase of proglucagon mRNA expression and the number of L-cell compared with the controls (P<0.05). Furthermore, BBR increased insulin levels in plasma and pancreas as well as β-cell number in pancreas. The data support the hypothesis that the anti-diabetic effects of BBR may partly result from enhancing GCG secretion.
Joint International Research Laboratory of Agriculture and Agri-Product Safety, The Ministry of Education of China, Yangzhou University, Yangzhou, Jiangsu, China
Search for other papers by Jinglin Zhang in
Google Scholar
PubMed
Search for other papers by Jie Gao in
Google Scholar
PubMed
Search for other papers by Di Zhang in
Google Scholar
PubMed
Search for other papers by Hui Liu in
Google Scholar
PubMed
Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou, Jiangsu, China
Search for other papers by Kemian Gou in
Google Scholar
PubMed
State Key Laboratory of Agrobiotechnology, College of Biological Sciences, China Agricultural University, Beijing, China
Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou, Jiangsu, China
Search for other papers by Sheng Cui in
Google Scholar
PubMed
Prolactin (PRL) is a pituitary hormone that regulates multiple physiological processes. However, the mechanisms of PRL synthesis have not been fully elucidated. The aims of the present study were to study the functions and the related mechanisms of miR-375 regulating PRL synthesis. We initially found that miR-375 mainly expressed in the lactotrophs of mouse pituitary gland. To identify the function of miR-375 in the pituitary gland, the miR-375 knockout mice were generated by using Crispr/Cas9 technique. The results showed that miR-375 knockout resulted in the decline of pituitary PRL mRNA and protein levels by 75.7 and 60.4%, respectively, and the serum PRL level reduced about 46.1%, but had no significant effect on FSH, LH and TSH. Further, we identified that Estrogen receptor 1 (alpha) (Esr1) was a downstream molecule of miR-375. The real-time PCR and Western blot results showed that ESR1 mRNA and protein levels markedly decreased by 40.9 and 42.9% in the miR-375 knockout mouse pituitary, and these were subsequently confirmed by the in vitro study using transfections of miR-375 mimics and inhibitors in pituitary lactotroph GH4 cells. Further, Rasd1 was predicted by bioinformatic tools and proved to be the direct target of miR-375 in lactotrophs using the dual-luciferase reporter assay. Rasd1-siRNA transfection results revealed the negative effect of Rasd1 in regulating ESR1. Collectively, the results presented here demonstrate that miR-375 positively modulates PRL synthesis through Rasd1 and Esr1, which are crucial for understanding the regulating mechanisms of pituitary hormone synthesis.
Department of Biology, Shantou University, Shantou, China
Search for other papers by Jie Liu in
Google Scholar
PubMed
Search for other papers by Fei Gao in
Google Scholar
PubMed
Search for other papers by Yue-Fang Liu in
Google Scholar
PubMed
Search for other papers by Hai-Ting Dou in
Google Scholar
PubMed
Search for other papers by Jia-Qi Yan in
Google Scholar
PubMed
Search for other papers by Zong-Min Fan in
Google Scholar
PubMed
Search for other papers by Zeng-Ming Yang in
Google Scholar
PubMed
Embryo implantation and decidualization are key steps for successful reproduction. Although numerous factors have been identified to be involved in embryo implantation and decidualization, the mechanisms underlying these processes are still unclear. Based on our preliminary data, Prss56, a trypsin-like serine protease, is strongly expressed at implantation site in mouse uterus. However, the expression, regulation and function of Prss56 during early pregnancy are still unknown. In mouse uterus, Prss56 is strongly expressed in the subluminal stromal cells at implantation site on day 5 of pregnancy compared to inter-implantation site. Under delayed implantation, Prss56 expression is undetected. After delayed implantation is activated by estrogen, Prss56 is obviously induced at implantation site. Under artificial decidualization, Prss56 signal is seen at the primary decidual zone at the initial stage of artificial decidualization. When stromal cells are induced for in vitro decidualization, Prss56 expression is significantly elevated. Dtprp expression under in vitro decidualization is suppressed by Prss56 siRNA. In cultured stromal cells, HB-EGF markedly stimulates Prss56 expression through EGFR/ERK pathway. Based on promoter analysis, we also showed that Egr2 is involved in Prss56 regulation by HB-EGF. Collectively, Prss56 expression at implantation site is modulated by HB-EGF/EGFR/ERK signaling pathway and involved in mouse decidualization.
Search for other papers by Caiping Mao in
Google Scholar
PubMed
Search for other papers by Rong Liu in
Google Scholar
PubMed
Search for other papers by Le Bo in
Google Scholar
PubMed
Search for other papers by Ningjing Chen in
Google Scholar
PubMed
Search for other papers by Shigang Li in
Google Scholar
PubMed
Search for other papers by Shuixiu Xia in
Google Scholar
PubMed
Search for other papers by Jie Chen in
Google Scholar
PubMed
Search for other papers by Dawei Li in
Google Scholar
PubMed
Institute for Fetology and Reproductive Medicine Center, Center for Prenatal Biology, First Hospital of Soochow University, Suzhou 215006, People's Republic of China
Search for other papers by Lubo Zhang in
Google Scholar
PubMed
Institute for Fetology and Reproductive Medicine Center, Center for Prenatal Biology, First Hospital of Soochow University, Suzhou 215006, People's Republic of China
Search for other papers by Zhice Xu in
Google Scholar
PubMed
Intrauterine environments are related to fetal renal development and postnatal health. Influence of salty diets during pregnancy on renal functions and renin–angiotensin system (RAS) was determined in the ovine fetuses and offspring. Pregnant ewes were fed high-salt diet (HSD) or normal-salt diet (NSD) for 2 months during middle-to-late gestation. Fetal renal functions, plasma hormones, and mRNA and protein expressions of the key elements of renal RAS were measured in the fetuses and offspring. Fetal renal excretion of sodium was increased while urine volume decreased in the HSD group. Fetal blood urea nitrogen was increased, while kidney weight:body weight ratio decreased in the HSD group. The altered ratio was also observed in the offspring aged 15 and 90 days. Maternal and fetal plasma antidiuretic hormone was elevated without changes in plasma renin activity and Ang I levels, while plasma Ang II was decreased. The key elements of local renal RAS, including angiotensinogen, angiotensin converting enzyme (ACE), ACE2, AT1, and AT2 receptor expression in both mRNA and protein, except renin, were altered following maternal high salt intake. The results suggest that high intake of salt during pregnancy affected fetal renal development associated with an altered expression of the renal key elements of RAS, some alterations of fetal origins remained after birth as possible risks in developing renal or cardiovascular diseases.
Search for other papers by Xuanchun Wang in
Google Scholar
PubMed
Search for other papers by Wei Gong in
Google Scholar
PubMed
Search for other papers by Yu Liu in
Google Scholar
PubMed
Search for other papers by Zhihong Yang in
Google Scholar
PubMed
Search for other papers by Wenbai Zhou in
Google Scholar
PubMed
Search for other papers by Mei Wang in
Google Scholar
PubMed
Search for other papers by Zhen Yang in
Google Scholar
PubMed
Search for other papers by Jie Wen in
Google Scholar
PubMed
Search for other papers by Renming Hu in
Google Scholar
PubMed
We report the identification of a novel secreted peptide, INM02. The mRNA transcript of human INM02 gene is about 3.0 kb. Its open-reading frame contains 762 bps and encodes a protein of 254 amino acids. Northern blot analysis demonstrates that INM02 mRNA is widely expressed in rat tissues, especially with abundant quantities in pancreatic islets, testis, and bladder tissue. We have expressed recombinant INM02 protein and generated rabbit anti-INM02 polyclonal antibodies. We show here that INM02 could be detectable in human serum by ELISA. We also present evidence that INM02 mRNA expression could be regulated by glucose. Experiments on both MIN6 cells and intact isolated islets demonstrate that INM02 mRNA levels are increased more than threefold by high glucose (25 mM) when compared with low glucose (5.5 mM). ELISA analysis shows that secretion of INM02 is significantly augmented by high glucose in vitro. It is speculated that as a novel secreted protein, INM02 is associated with functions of pancreatic islets, especially of β-cells.
Medical College, Nantong University, Nantong, Jiangsu Province, China
Search for other papers by Hong Ma in
Google Scholar
PubMed
Search for other papers by Jin Yuan in
Google Scholar
PubMed
Search for other papers by Jinyu Ma in
Google Scholar
PubMed
Search for other papers by Jie Ding in
Google Scholar
PubMed
Search for other papers by Weiwei Lin in
Google Scholar
PubMed
Search for other papers by Xinlei Wang in
Google Scholar
PubMed
Search for other papers by Mingliang Zhang in
Google Scholar
PubMed
Medical College, Nantong University, Nantong, Jiangsu Province, China
Search for other papers by Yi Sun in
Google Scholar
PubMed
Medical College, Nantong University, Nantong, Jiangsu Province, China
Search for other papers by Runze Wu in
Google Scholar
PubMed
Search for other papers by Chun Liu in
Google Scholar
PubMed
Search for other papers by Cheng Sun in
Google Scholar
PubMed
Search for other papers by Yunjuan Gu in
Google Scholar
PubMed
Bone morphogenetic protein 7 (BMP7), a member of the transforming growth factor-β (TGF-β) family, plays pivotal roles in energy expenditure. However, whether and how BMP7 regulates hepatic insulin sensitivity is still poorly understood. Here, we show that hepatic BMP7 expression is reduced in high-fat diet (HFD)-induced diabetic mice and palmitate (PA)-induced insulin-resistant HepG2 and AML12 cells. BMP7 improves insulin signaling pathway in insulin resistant hepatocytes. On the contrary, knockdown of BMP7 further impairs insulin signal transduction in PA-treated cells. Increased expression of BMP7 by adenovirus expressing BMP7 improves hyperglycemia, insulin sensitivity and insulin signal transduction. Furthermore, BMP7 inhibits mitogen-activated protein kinases (MAPKs) in both the liver of obese mice and PA-treated cells. In addition, inhibition of MAPKs recapitulates the effects of BMP7 on insulin signal transduction in cultured hepatocytes treated with PA. Activation of p38 MAPK abolishes the BMP7-mediated upregulation of insulin signal transduction both in vitro and in vivo. Together, our results show that hepatic BMP7 has a novel function in regulating insulin sensitivity through inhibition of MAPKs, thus providing new insights into treating insulin resistance-related disorders such as type 2 diabetes.
